Individualized image guided iso-NTCP based liver cancer SBRT

References

• Ben-Josef E, Normolle D, Pan C, Tatro D, Ten Haken RK, Knol J, et al. A Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 2005; 23: 8739–47
   PubMed Web of Science ®Google Scholar
• Dawson LA, Lawrence TS. The role of radiotherapy in the treatment of liver metastases. Cancer J 2004; 10: 139–44
   PubMedGoogle Scholar
• Hawkins M, Dawson L. From palliation to cure: Radiotherapy for hepatocellular carcinoma. Cancer 2006; 106: 1653–63
   PubMed Web of Science ®Google Scholar
• Dawson L, Sharpe M. Image guided radiation therapy: Rationale, benefits and cautions. Lancet Oncol 2006; (in press).
   PubMedGoogle Scholar
• Wong JW, Sharpe MB, Jaffray DA, Kini VR, Robertson JM, Stromberg JS. The use of active breathing control (ABC) to reduce margin for breathing motion. Int J Radiat Oncol Biol Phys J1. Int J Radiat Oncol Biol Phys J2-Red J 1999; 44: 911–9
   PubMed Web of Science ®Google Scholar
• Rietzel E, Pan T, Chen G. Four-dimensional computed tomography: Image formation and clinical protocol. Med Phys 2005; 32: 874–89
   PubMed Web of Science ®Google Scholar
• Brock KK, Dawson LA, Sharpe MB, Moseley DJ, Jaffray DA. Feasibility of a novel deformable image registration technique to facilitate classification, targeting, and monitoring of tumor and normal tissue. Int J Radiat Oncol Biol Phys 2006; 64: 1245–54
   PubMed Web of Science ®Google Scholar
• Dawson LA, Normolle D, Balter J, McGinn CJ, Lawrence TS, Ten Haken RK. Analysis of radiation induced liver disease using the lyman NTCP model. Int J Radiat Oncol Biol Phys 2002; 53: 810–21
   PubMed Web of Science ®Google Scholar
• Kutcher GJ, Burman C, Brewster L, Goitein M, Mohan R. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys 1991; 21: 137–46
   PubMed Web of Science ®Google Scholar
• Sonke JJ, Zijp L, Remeijer P, van Herk M. Respiratory correlated cone beam CT. Med Phys 2005; 32: 1176–86
   PubMed Web of Science ®Google Scholar
• Dawson L, Eccles C, Kirilova A, Brock K. Three dimensional motion of liver tumours using cine MRI compared to liver motion assessed at fluoroscopy. A483. Rad. Oncol 2004; 73(Suppl 1)S214
   Google Scholar
• Eccles CL, Brock KK, Hawkins M, Bissonnette JP, Dawson LA. Reproducibility of liver position using active breathing coordinator for liver cancer radiotherapy. Int J Radiat Oncol Biol Phys 2006; 64(3)751–759
   PubMed Web of Science ®Google Scholar
• Voroney J, Brock K, Eccles C, Haider M, Dawson LA. Prospective comparison of CT and MR for liver cancer delineation using deformable image registration. Int J Radiat Oncol Biol Phys 2006; (in press).
   PubMedGoogle Scholar
• Dawson LA, Eccles C, Bissonnette JP, Brock KK. Accuracy of daily image guidance for hypofractionated liver radiotherapy with active breathing control. Int J Radiat Oncol Biol Phys 2005; 62: 1247–52
   PubMed Web of Science ®Google Scholar
• Hawkins M, Brock K, Eccles C, Moseley D, Jaffray DA, Dawson LA. Assessment of residual error in liver position using kV cone-beam CT for liver cancer high precision radiation therapy. Int J Radiat Oncol Biol Phys 2006; (in press).
   Google Scholar
• Ten Haken RK, Martel MK, Kessler ML, Hazuka MB, Lawrence TS, Robertson JM, Turrisi AT, Lichter AS. Use of Veff and iso-NTCP in the implementation of dose escalation protocols. Int J Radiat Oncol Biol Phys 1993; 27: 689–95
   PubMedGoogle Scholar
• McGinn CJ, Ten Haken RK, Ensminger WD, Walker S, Wang S, Lawrence TS. Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model. J Clin Oncol 1998; 16: 2246–52
   PubMedGoogle Scholar
• Mohiuddin MCE, Ahmad N. Combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer. J Clin Oncol 1996; 14: 722–8
   PubMed Web of Science ®Google Scholar
• Seong JPH, Han KH, Chon CY. Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: A retrospective study of 158 patients. Int J Radiat Oncol Biol Phys 2003; 55: 329–36
   PubMed Web of Science ®Google Scholar
• Blomgren H, Lax I, Naslund I, Svanstrom R. Steretactic high dose fraction radiation therapy of extracranial tumours using an acclerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995; 34: 861–70
   PubMed Web of Science ®Google Scholar
• Fuss M, Thomas CR. Stereotactic body radiation therapy: An ablative treatment option for primary and secondary liver tumors; Ann Surg Oncol 11(2); 2004. p. 130–8.
   PubMedGoogle Scholar
• Herfarth KK, Debus J, Wannenmacher M. Stereotactic radiation therapy of liver metastases: Update of the initial phase-I/II trial. Front Radiat Ther Oncol 2004; 38: 100–5
   PubMedGoogle Scholar
• Schefter TE, Kavanagh BD, Timmerman RD, Cardenes HR, Baron A, Gaspar LE. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 2005; 62: 1371–8
   PubMed Web of Science ®Google Scholar
• Wulf J, Hadinger U, Oppitz U, Thiele W, Flentje M. Stereotactic boost irradiation for targets in the abdomen and pelvis. Radiol Oncol 2004; 70(1)31–6
   Google Scholar